Pacific Bio (PACB) Q3 Revenue Misses Estimates

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of $0.02, may not compare to the analyst estimate of ($0.27). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $15.84 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• Six Flags names Mark Pauls as chief operating officer